Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

non-amyloid fibrillary glomerulopathy - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

non-amyloid fibrillary glomerulopathy

MONDO:0019990

Also known as:Congo red-negative amyloidosis-like glomerulopathyFibrillary Glomerulonephritis non-amyloid fibrillary glomerulonephritis

Find Clinical TrialsTrials

Overview

Non-amyloid fibrillary glomerulopathy (non-amyloid FGP) is a rare cause of glomerulonephritis (GN) characterized by glomerular accumulation of non-amyloid fibrils in the mesangium and the glomerular (and rarely tubular) basement membrane, that mainly presents with renal insufficiency, micro-hematuria and nephrotic range proteinuria. Non-amyloid FGP and immunotactoid glomerulopathy (ITG) are often grouped together as pathogenetically related diseases.

Clinical Trials2 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for non-amyloid fibrillary glomerulopathy has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.

57 publications have been identified in PubMed for non-amyloid fibrillary glomerulopathy. Kisho has analyzed 31 by research type. Research spans Case Report / Case Series (45%), Review / Meta-Analysis (29%), and Clinical Trial Publication (10%).

Research Type	Count	% of Total
Patient case studies	14

Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 9:21 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:97566

GARD

Genetic and Rare Diseases Info Center

GARD:12740

Questions for Your Care Team

→Are any of the 2 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

non-amyloid fibrillary glomerulopathy

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications